CC
Casdin Capital, LLC
New York NY · SEC CIK 0001534261
$2.00B2026Q2 reported value
43Positions
77.4%Top 10 weight · largest 24.2%
4 / 3New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
WGS Added+$48.06M
RLAY Added+$30.25M
SION New+$17.60M
SRRK Added+$17.32M
GRAL Added+$17.07M
2026Q2 top sells estimated at quarter-end value
TXG Reduced-$46.97M
BIOLIFE SOLUTION Reduced-$36.77M
GH Reduced-$19.50M
QGEN Sold out-$14.41M
TEM Sold out-$13.30M
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | $482.68M | 24.16% | 2,577,333 | 0 | 0.0% | — | Unchanged |
| RLAY | RELAY THERAPEUTICS INC | $300.02M | 15.02% | 16,035,240 | 1,616,666 | 11.2% | $30.25M | Added |
| WGS | GENEDX HOLDINGS CORP | $254.50M | 12.74% | 3,707,164 | 700,000 | 23.3% | $48.06M | Added |
| — | BIOLIFE SOLUTIONS INC | $131.46M | 6.58% | 4,655,000 | -1,302,165 | -21.9% | -$36.77M | Reduced |
| ILMN | ILLUMINA INC | $93.19M | 4.66% | 530,000 | 0 | 0.0% | — | Unchanged |
| LAB | STANDARD BIOTOOLS INC | $73.04M | 3.66% | 88,783,856 | 0 | 0.0% | — | Unchanged |
| GPCR | STRUCTURE THERAPEUTICS INC | $63.06M | 3.16% | 1,175,000 | 0 | 0.0% | — | Unchanged |
| DNLI | DENALI THERAPEUTICS INC | $52.60M | 2.63% | 2,045,000 | 205,000 | 11.1% | $5.27M | Added |
| NGNE | NEUROGENE INC | $48.60M | 2.43% | 1,545,361 | 125,000 | 8.8% | $3.93M | Added |
| BEAM | BEAM THERAPEUTICS INC | $46.33M | 2.32% | 1,350,000 | 0 | 0.0% | — | Unchanged |
| TXG | 10X GENOMICS INC | $40.26M | 2.02% | 1,050,000 | -1,225,000 | -53.8% | -$46.97M | Reduced |
| SRRK | SCHOLAR ROCK HLDG CORP | $36.58M | 1.83% | 665,000 | 315,000 | 90.0% | $17.32M | Added |
| PSNL | PERSONALIS INC | $34.17M | 1.71% | 2,550,000 | 950,000 | 59.4% | $12.73M | Added |
| GRAL | GRAIL INC | $32.77M | 1.64% | 480,000 | 250,000 | 108.7% | $17.07M | Added |
| GH | GUARDANT HEALTH INC | $27.76M | 1.39% | 185,000 | -130,000 | -41.3% | -$19.50M | Reduced |
| MAZE | MAZE THERAPEUTICS INC | $25.18M | 1.26% | 843,857 | 85,000 | 11.2% | $2.54M | Added |
| HIMS | HIMS & HERS HEALTH INC | $24.27M | 1.21% | 700,000 | 0 | 0.0% | — | Unchanged |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $22.58M | 1.13% | 75,000 | 0 | 0.0% | — | Unchanged |
| TSHA | TAYSHA GENE THERAPIES INC | $22.13M | 1.11% | 3,250,000 | 0 | 0.0% | — | Unchanged |
| AGMB | AGOMAB THERAPEUTICS NV | $20.12M | 1.01% | 1,550,000 | 0 | 0.0% | — | Unchanged |
| SEPN | SEPTERNA INC | $18.53M | 0.93% | 553,268 | 0 | 0.0% | — | Unchanged |
| PBLS | PARABILIS MEDICINES INC | $17.67M | 0.88% | 645,690 | 645,690 | — | — | First reported |
| SION | SIONNA THERAPEUTICS INC | $17.60M | 0.88% | 400,000 | 400,000 | — | $17.60M | New |
| VCYT | VERACYTE INC | $16.23M | 0.81% | 276,308 | 0 | 0.0% | — | Unchanged |
| ANL | ADLAI NORTYE LTD | $14.38M | 0.72% | 1,250,000 | 711,539 | 132.1% | $8.18M | Added |
| PRME | PRIME MEDICINE INC | $11.69M | 0.58% | 3,167,175 | 0 | 0.0% | — | Unchanged |
| ABSI | ABSCI CORPORATION | $11.28M | 0.56% | 973,260 | 0 | 0.0% | — | Unchanged |
| DGX | QUEST DIAGNOSTICS INC | $10.60M | 0.53% | 50,000 | 0 | 0.0% | — | Unchanged |
| SRPT | SAREPTA THERAPEUTICS INC | $8.45M | 0.42% | 470,000 | 470,000 | — | $8.45M | New |
| QURE | UNIQURE NV | $6.91M | 0.35% | 150,000 | 150,000 | — | $6.91M | New |
| NTLA | INTELLIA THERAPEUTICS INC | $6.01M | 0.30% | 355,000 | 0 | 0.0% | — | Unchanged |
| MRNA | MODERNA INC | $5.25M | 0.26% | 75,000 | 0 | 0.0% | — | Unchanged |
| IRON | DISC MEDICINE INC | $4.75M | 0.24% | 65,000 | 0 | 0.0% | — | Unchanged |
| GLUE | MONTE ROSA THERAPEUTICS INC | $4.50M | 0.23% | 186,014 | 0 | 0.0% | — | Unchanged |
| IPSC | CENTURY THERAPEUTICS INC | $3.01M | 0.15% | 1,228,190 | 0 | 0.0% | — | Unchanged |
| CTNM | CONTINEUM THERAPEUTICS INC | $2.43M | 0.12% | 148,333 | 0 | 0.0% | — | Unchanged |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | $2.15M | 0.11% | 282,312 | 0 | 0.0% | — | Unchanged |
| EDIT | EDITAS MEDICINE INC | $1.44M | 0.07% | 445,000 | 445,000 | — | $1.44M | New |
| PACB | PACIFIC BIOSCIENCES CALIF IN | $1.22M | 0.06% | 723,767 | 0 | 0.0% | — | Unchanged |
| KARD | KARDIGAN INC | $1.19M | 0.06% | 50,000 | 50,000 | — | — | First reported |
| RXRX | RECURSION PHARMACEUTICALS IN | $606,735 | 0.03% | 165,323 | 0 | 0.0% | — | Unchanged |
| DNA | GINKGO BIOWORKS HOLDINGS INC | $361,646 | 0.02% | 36,493 | 0 | 0.0% | — | Unchanged |
| — | TENAYA THERAPEUTICS INC | $267,531 | 0.01% | 361,969 | 0 | 0.0% | — | Unchanged |
| QGEN | QIAGEN NV | $0 | 0.00% | 0 | -360,000 | -100.0% | -$14.41M | Sold out |
| TEM | TEMPUS AI INC | $0 | 0.00% | 0 | -294,127 | -100.0% | -$13.30M | Sold out |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $0 | 0.00% | 0 | -450,000 | -100.0% | -$8.39M | Sold out |